{"id":"NCT00362609","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD","officialTitle":"A Multicenter, Open-Label, PK, PD and Safety Study of Pantoprazole Delayed-Release Granules Administered as a Suspension in Neonates and Preterm Infants With a Clinical Diagnosis of GERD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2006-08-10","resultsPosted":"2010-05-14","lastUpdate":"2010-05-14"},"enrollment":59,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gastroesophageal Reflux"],"interventions":[{"type":"DRUG","name":"pantoprazole","otherNames":[]}],"arms":[{"label":"Low dose","type":"ACTIVE_COMPARATOR"},{"label":"High dose","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine whether or not consistent drug levels can be achieved in infants with presumed Gastroesophageal Reflux Disease.","primaryOutcome":{"measure":"Variance of Oral Bioavailability","timeFrame":"1 day","effectByArm":[{"arm":"1.25 mg Pantoprazole","deltaMin":1.07,"sd":2.59},{"arm":"2.5 mg Pantoprazole","deltaMin":0.74,"sd":2.29}],"pValues":[]},"eligibility":{"minAge":"1 Day","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":71,"countries":["United States","Australia","Belgium","Canada","France","Germany","Italy","Netherlands","Poland","South Africa","Switzerland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Anemia","Hypoxia","Constipation","Rhinitis","Bradycardia"]}}